Daniel Song

Daniel Song is a seasoned professional in the pharmaceutical industry with extensive experience in analytics and forecasting. Currently serving as the Senior Director of Integrated Insights and Analytics and Antivirals Lead at Pfizer since November 2024, Daniel previously held multiple roles at Pfizer, including Director of Global Comirnaty Forecasting and Director of mRNA Global Dose Allocation, where contributions focused on the global distribution of the Comirnaty vaccine. Prior experience includes roles at Amgen, leading the commercial strategy and analytics for Neulasta, and at Gilead Sciences, managing forecasting for HIV and PrEP portfolios during multiple product launches. Daniel's career began at Charles River Associates and IQVIA, where skills in market research and decision modeling were honed. Daniel holds a Master's of Engineering in Engineering/Industrial Management and a Bachelor of Science in Chemical Engineering from Cornell University.